Contact Customer Service: 1-800-798-6972, Mon-Fri: 9am to 5pm ET

The Tacticon

The Tacticon uses circumference discrimination thresholds to conduct quantitative sensory testing (QST) as recommended by the American Diabetes Association Consensus Panels on Diabetic Peripheral Neuropathy.

Availability: In stock

$399.00

Details

Details

The Tacticon is a small, hand held, passive medical device that the FDA has approved to screen patients for evidence of subclinical peripheral neuropathy of the fingers and toes. It uses circumference discrimination threshold testing, which has been found to be positively correlated with vibratory threshold testing. The Tacticon permits quantitative sensory testing (QST) as recommended by the American Diabetes Association Consensus Panels on Diabetic Peripheral Neuropathy. A Cross-Sectional Study Comparing Two Quantitative Sensory Testing Devices in Individuals With Diabetes demonstrated that increasing thresholds for large sensory nerve fibers (i.e., vibratory thresholds) were associated with decreasing ability to discriminate circumference. The study examined agreement of these two QST devices for the detection of the presence of nerve fiber dysfunction and found the agreement between two QST devices is in the fair-to-good range, with better agreement in the <50 years age-group. Traditional electronic vibrational QST Devices can cost upward of $3400 The Tacticon is inexpensive, portable and easy to use. Each Tacticon comes with all the necessary forms and a training video.

Additional Info

Additional Info

Shipping and Return Policy Please see Shipping and Return Policies

Video



We do not have a video filmed for this product yet.

Do you think we need one? Email us and let us know!

Reviews

Write Your Own Review

You're reviewing: The Tacticon

Tags

Tags

Use spaces to separate tags. Use single quotes (') for phrases.

Privacy Policy | Shipping & Return Policies

Contact Customer Service: 1-800-798-6972

© 2014 HIPER, LLC. All Rights Reserved.